No Data
No Data
Leerink Partners Maintains CVS Health(CVS.US) With Hold Rating, Cuts Target Price to $51
CVS Faces DOJ Lawsuit Alleging Violations Of Controlled Substances Act And False Claims Act Over Opioid Prescriptions
Dow Tanks as Powell Sends Shockwaves. This Is No Time To Panic.
CVS's 'Violations Resulted From Corporate-Mandated Performance Metrics, Incentive Compensation, and Staffing Policies That Prioritized Corporate Profits,' DOJ Alleges
CVS Pharmacy, Various Units Filled Unlawful Prescriptions in Violation of Controlled Substances Act, Justice Department Alleges
CVS Health Options Spot-On: On December 18th, 94,776 Contracts Were Traded, With 875.2K Open Interest
No Data